Four prominent medical device makers headquartered in Orange County this afternoon reported first-quarter sales that topped analysts’ expectations.
Brea-based Envista Corp. (NYSE: NVST) said first-quarter sales climbed 3.1% to $631.4 million and its profit was 47 cents a share. Analysts on average expected $628.4 million and a 43-cent profit per share. Shares of the dental equipment supplier rose 7.7% in after-hours trading.
Lake Forest-based Staar Surgical (Nasdaq: STAA) reported a 19-cent profit per share on sales of $63.3 million, better than the analysts’ estimates for an 8-cent profit per share on sales of $60.5 million. Shares of the maker of implantable lenses climbed 6.5% to $68.
Glaukos Corp. (NYSE: GKOS) reported a loss of 36 cents a share on sales of $67.7 million, topping the expectation for a 50-cent loss per share on $60.9 million. Shares of the San Clemente-based maker of products to treat glaucoma rose 2.1% to $48.50 in after-hours trading.
Inari Medical Inc. (Nasdaq: NARI) reported $86.8 million in sales and a loss of 6 cents a share, topping the $83.6 million and 9-cent loss a share expected by analysts. Shares of the Irvine-based maker of products to treat vein clots fell less than 1% after the results were announced.